JamesSamuelPopeMD

Pulmonology • Hartford, CT

Critical Care Medicine

Medical Director, Medical ICU Hartford Hospital

Join to view full profile

Dr. Pope is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pope's full profile

Already have an account?

Office
80 Seymour Street
Hartford, CT 06106
Phone+1 860-972-0001

Education & Training

University of Virginia Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
University of Virginia Medical CenterResidency, Internal Medicine, 1999 - 2003
University of Virginia School of MedicineClass of 1999

Certifications & Licensure

CT State Medical License 2006 - 2025
VA State Medical License 1999 - 2006
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Top MD Consumers Checkbook
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Clinical Trials

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 Start of enrollment: 2020 Aug 19
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.
Christina Koenig, Marguerite L Monogue, Ryan K Shields, Colleen M Sakon, Andrew J Fratoni
Antimicrobial Agents and Chemotherapy. 2024-12-10
73 citations
Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.
Kevin P. Connors, Seth T. Housman, J. Samuel Pope, John Russomanno, Edward Salerno
Antimicrobial Agents and Chemotherapy. 2014-04-01
86 citations
Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
Seth T. Housman, J. Samuel Pope, John Russomanno, Edward Salerno, Eric Shore
Antimicrobial Agents and Chemotherapy. 2012-05-01

Press Mentions

Biden Signs Law to Support the Mental Health of Medical WorkersMarch 19th, 2022
[WATCH] Doctors Burned Out from Treating Unvaccinated PatientsJanuary 22nd, 2022
US Covid Doc: We Are 'Burned Out'January 19th, 2022